The causes of knee pain in patients with cancer with are different from those without cancer, and the purpose of this study was to evaluate these differences. Thirty-six patients with cancer who had knee pain who had undergone 1 or more modalities of treatment, including chemotherapy, radiotherapy, and bone marrow transplant, for a primary diagnosis of cancer were compared with a cohort of 40 patients without cancer who had knee pain. All patients were evaluated clinically and underwent radiographic examination, and some underwent computed tomography or magnetic resonance imaging examination. Among patients with a primary diagnosis of cancer, the most common diagnosis was lymphoma (n510), and the most common causes of knee pain were avascular necrosis of bone, osteoarthritis, insufficiency fractures, and septic arthritis. In 5 patients, the classical signs of a septic knee were not present. Other causes of knee pain included meniscus tear and anterior cruciate ligament rupture with instability. The most common diagnosis in patients without cancer was osteoarthritis of the knee. No patient without cancer was diagnosed with avascular necrosis, metastatic lesion, or insufficiency fracture. Two patients without cancer were diagnosed with septic arthritis of the knee.
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T he advancement of cancer treatment has led to improved survival rates.
However, chemotherapy-which may include prolonged steroid use-radiotherapy, and bone marrow transplantation often cause secondary complications. These modalities have the potential to damage bone, including causing osteoporosis, insufficiency fractures, and avascular necrosis of bone. 1, 2 Around the knee, areas of metaphyseal bone, such as the tibial plateau and distal femur, are also prone to develop these fractures. Avascular necrosis of bone has been documented after treatment with chemotherapy and prolonged steroid use and can lead to knee pain, subchondral bone collapse, and early osteoarthritis. [3] [4] [5] The authors' experience working at a national cancer center suggested that the etiology and management of knee pain in patients with cancer is different from that in patients without cancer. Based on this hypothesis, the authors studied knee pain in a cohort of patients with cancer and compared it with that in a group of patients without cancer to evaluate the clinical significance of this condition in the context of etiology and management, with the ultimate goal of reducing morbidity and patient distress.
Materials and Methods
Using an institutional review boardapproved protocol, data of patients with a diagnosis of knee pain between January 2007 and December 2009 were retrospectively reviewed. The study cohort comprised 76 patients with knee pain, of whom 36 were patients with a primary diagnosis of cancer who had undergone chemotherapy, radiotherapy, and/or bone marrow transplantation, and 40 were patients without cancer. Data were then compiled and analyzed to compare the findings in the 2 study cohorts.
Patient information was retrieved from a Cerner Power Chart electronic medical record system (Cerner Corporation, Kansas City, Missouri), which collects data for all patients presenting to the authors' institution. The cohort of cancer patients comprised 22 women and 14 men (age range, 21-79 years; mean, 54 years). The most common primary diagnosis was lymphoma (n510), followed by leukemia (n57) and lung metastasis (n57) ( Table  1) . Variables accessed for all patients were age, sex, primary cancer diagnosis, date of chemotherapy, drugs used, and drug dosage and duration. Information regarding bone marrow transplantation and radiotherapy, if given, was also recorded. The presence of avascular necrosis and whether bisphosphonates or steroids were administered were noted. All patients underwent chemotherapy, 25 patients underwent adjuvant radiotherapy, and 16 patients underwent bone marrow transplantation (Tables 2, 3 ).
All patients were evaluated radiographically. Thirty-three patients underwent magnetic resonance imaging (MRI) of the knee. All patients who presented with swelling of the knee (n518) had the joint aspirated, and the fluid was sent for examination.
A control group of 40 consecutive patients without a primary diagnosis of cancer who presented with knee pain were also evaluated clinically and radiographically. When indicated, patients underwent MRI or computed tomography examination. In addition, patients with knee effusion were aspirated if suspicion of septic arthritis existed.
When patients presented with knee pain, an algorithm was used to determine the cause of pain (Figure 1 ). Patients were interviewed regarding the history of their knee pain and the quality of symptoms, and they underwent a standard orthopedic examination of the knee, including radiographic examination. Many patients with cancer were immunocompromised and at risk for septic arthritis; hence, the threshold for a knee aspiration was low, and the mere presence of knee effusion was an indication. In patients without cancer, knees were aspirated only if the physical examination raised suspicion for infection, and the fluid was obtained for examination. Gram staining, cell count, examination for crystals of gout and pseudo gout, and culture were performed on the fluid. In patients with a negative fluid examination, other causes of the pain were sought with computed tomography or MRI.
results

Cancer Patients
The cause of knee pain was determined to be avascular necrosis of bone in 14 patients, osteoarthritis in 12 patients, and metastatic lesion in 8 patients (Figure 2 ). Avascular necrosis (Figure 3 ) was associated with insufficiency fractures ( Figure  4 ) in 6 patients and with septic arthritis in 4 patients. Of the 14 patients who developed avascular necrosis, 13 were taking a regimen of steroids. Three patients were also taking bisphosphonates.
A total of 16 patients had bone marrow transplantation. Eleven patients had avascular necrosis, 6 patients had septic arthritis, and 2 patients each had osteoarthritis and metastatic lesions. Among all cancer patients, 18 were diagnosed with more than 1 cause of knee pain (Tables 1, 2) .
A total of 18 knees were aspirated, and 6 patients were diagnosed with septic arthritis. The organisms responsible for infection in the patients were Burkholderia Multiple myeloma 3
Germ cell tumor 1
Myelodysplastic syndrome 1
Renal cell carcinoma 1 cepacia, Enterobacter cloacae, Serratia marcescens, and Klebsiella pneumoniae. In 4 of these patients, the infection was superimposed on avascular necrosis of the underlying bone.
Patients Without Cancer
Patients without cancer comprised 26 men and 14 women with an average age of 50 years (range, 18-81 years). The most common diagnosis was osteoarthritis (n513); 2 patients had an associated baker's cyst (Table 4) . Staphylococcus aureus was isolated in 2 patients with septic arthritis. Both patients had used illicit drugs. No patient had avascular 
discussion
This study highlights the causes of knee pain in patients with cancer, which are different from those observed in those without cancer. In patients without cancer aged 50 years or older, osteoarthritis is the most common cause of knee pain. 6 In younger patients without cancer, acute trauma, systemic inflammatory disease, including rheumatoid arthritis, and gout may cause knee pain. Acute meniscal injuries commonly occur in older athletes with degenerative meniscal tears. Less common causes include tendinitis and bursitis. Posterior knee pain may arise from a Baker's cyst or from the lower back. Occasionally, anterior knee pain may arise from a hip disorder. In the current study, in 68% (23/36) of patients with cancer, none of the above was a cause of pain; rather, the most common cause of knee pain was avascular necrosis of bone.
As also noted by Enright et al, 7 the current study found a link between previous allogenic bone marrow transplantation and avascular necrosis. 7 In the current study, 11 of 16 patients who had undergone bone marrow transplantation developed avascular necrosis. Six of these patients also had septic arthritis. Recently, avascular necrosis has been increasingly recognized as a major complication in the treatment diseases such as acute lymphoblastic leukemia in children. 8, 9 Corticosteriods, given for treatment of various diseases such as malignancies and renal diseases, are known to cause avascular necrosis.
3,4 Avascular necrosis occurs in up to 52% of patients receiving glucocorticoids but has been primarily associated with prolonged glucocorticoid use. 4, 5 It has also been reported that the dosage is directly related to the number of osteonecrotic lesions, and a high dose is a significant risk factor for multifocal osteonecrosis with epiphyseal and diaphyseal lesions. 10 Prednisone has often been substituted by dexamethasone for its potent antileukemic effect, resulting in an increased incidence of avascular necrosis. 8 In the current study, a high incidence of avascular necrosis was associated with steroid use. Thirteen (92.8%) of 14 patients diagnosed with avascular necrosis were taking steroids, confirming previous reports. [3] [4] [5] A combination of standard radiography and MRI techniques are used to diagnose avascular necrosis. Avascular necrosis associated with cancer has been extensively described in children 8, 9 ; however, reports are lacking in adults.
In the current study, 8 patients with cancer displayed metastasis around the 
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knee, with metastasis from the lung being the most common (n54), followed by metastasis from the breast. One case of metastasis from the kidney existed. Studies report that bone metastases are a common occurrence from the breast and prostate in nearly 70% patients with advanced disease. The lung, kidney, and thyroid are the next most common organs, with other sites, including the gastrointestinal tract, being uncommon.
11,12
Metastatic lesions may be lytic, blastic, or mixed depending on the site of the primary tumor. 13 Prostate cancer typically produces blastic lesions, whereas most others are lytic. Breast cancer is blastic in a small minority of patients. Lung cancer produces a mixed appearance, and if a lesion is distal to the elbow or knee, lung cancer is the most likely primary lesion. The highly vascular metaphyseal bone is the preferred site for bone metastases due to the presence of hairpin bends in the vasculature, resulting in a sluggish sinusoidal vascular supply. This provides a setting for the invading tumor cells to move in and out of the marrow. In addition, the endothelial cells secrete several adhesive molecules that enhance extravasation of tumor cells into the marrow. 12 Septic arthritis does not commonly occur in healthy adults. Use of intravenous drugs is a significant risk factor. In patients with cancer, septic arthritis occurs due to the immunocompromised state of the patient. 14 In the current study, 18 patients with cancer presented with knee swelling. All swollen knees were aspirated. Six (29.4%) patients had a positive knee aspiration for infection, and 12 (70.6%) patients had negative knee aspirates with no complications. Of these, 1 presented with the classical clinical symptomatology of septic arthritis, including dolor, calor, rubor, and tumor. 14, 15 The diagnosis of septic arthritis in patients with cancer is complicated due to their immunocompromised state. This prevents patients from exhibiting classical symptoms, making its diagnosis a challenge.
It has been suggested that immunosuppressive drugs (eg, disease-modifying antirheumatic drugs and tumor necrosis factor [TNF] blockers) and steroid therapies may play a role in the development of septic arthritis. 16, 17 Tumor necrosis factor-a plays a crucial role in the body's defense against bacterial and viral invasion, particularly through the recruitment of neutrophils, eosinophils, and macrophages to the site of infections, as well as enhancing antigen presentation with recruitment and proliferation of T-and B-cells. A metaanalysis of several randomized trials of TNF-a inhibitors in rheumatoid arthritis found an increased risk of serious infections in the treatment groups compared with groups receiving placebo or diseasemodifying antirheumatic drugs. 17, 18 In the group without cancer, 2 patients were diagnosed with septic arthritis, and both had a history of intravenous drug abuse. Reports indicate that the involvement of the joint cavity results from the hematogenous spread of bacteria at the time of transient or sustained bacteremia following injection of narcotics using a nonsterile technique. 19 Alternatively, the infecting organisms may produce local disease at the injection site, and the adjacent joint may become infected by contiguous spread. 19 In the current study, the organisms responsible for infection in cancer patients were B cepacia, E cloacae, S marcescens and K pneumoniae, which are not common pathogens causing septic arthritis in the immunocompetent patient. The most common organism in the immunocompetent population is S aureus, which was isolated in both infected patients without cancer in this study. Furthermore, 4 (66.7%) of 6 patients with cancer and septic arthritis were on a regimen of steroids. Four patients also had avascular necrosis with associated knee infection. A literature review revealed limited reports of septic arthritis of the knee following chemotherapy or radiotherapy. However, septic arthritis has been reported in patients with other diseases that cause low patient immunity, such as rheumatoid arthritis. 17 Furthermore, the outcomes for this subpopulation are worse because most immunocompromised patients recover poorly from this disease. 20 In this patient population, it is important to aspirate knee swelling for fluid examination because many of these patients may have an underlying infection in the absence of clinical and laboratory parameters.
With recent advances in cancer treatment and the extensive use of modalities such as chemotherapy and radiotherapy, an increasing number of patients who are cured and live longer experience secondary problems such as osteoporosis. 21 Approximately 40% of White women and 13% of White men in the United States have at least 1 fragility fracture after the age of 50 years. 22 In these patients, the use of glucocorticoids is a major cause of bone loss. 21 In addition, many hormonal and nonhormonal treatments used today may promote bone loss by inducing hypogonadism, which increases bone resorption and bone turnover. 23 The fractures and microfractures resulting from osteoporosis are often a precursor to knee pain. In the current study, 8 patients were noted to have insufficiency fractures resulting in their presentation with knee pain. Periarticular osteoporosis of the knee is a risk factor for this event.
An insufficiency fracture occurs in weakened bone, which has decreased elastic resistance and fractures under normal physiologic stress. Patients with breast cancer are at an increased risk for estrogen deficiency due to age-related menopause, ovarian failure from systemic chemotherapy, or the use of drugs such as aromatase inhibitors and GnRH analogs. 21 Previous studies have reported a greater frequency of fractures in cancer patients compared with patients without cancer, 21 and this is evident by the fact that no patients without cancer were diagnosed with insufficiency fractures in the current study. In patients with avascular necrosis, it is important to look for these fractures, which are difficult to diagnose on imaging studies because the area of necrosis often is superimposed on the insufficiency fracture.
conclusion
Knee pain in patients with cancer after chemotherapy, radiotherapy, or bone marrow transplantation is commonly caused by avascular necrosis, metastatic disease, septic arthritis, and insufficiency fractures. These causes were absent or uncommon in patients without cancer, proving the hypothesis that the causes of knee pain in cancer patients are different from those in the normal population. Septic arthritis may present without the classical clinical signs in patients with cancer, and a high index of suspicion index must be maintained for it.
